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ABSTRACT
Objective: This study aimed to investigate the adverse effects of linezolid (LZD) on biochemical and hematological parameters and some organs 
including bone marrow, brain, and kidneys and to investigate the possibility of methanolic extract of Phoenix dactylifera (MEPD) to counteract the 
adverse effects of LZD.
Methods: Forty-eight adult male albino rats were allocated into four equal groups (each of 12 animals). The first group received Tween 80 orally. The 
second group received was given 0.5 ml of LZD suspension 4% in Tween 80 (100 mg/kg body weight) orally. The third group received the same dose 
of LZD suspension followed by 1 ml of MEPD orally. The rats in the last group were given 1 ml of MEPD (1000 mg/kg body weight) orally. Rats were 
sacrificed and blood samples were collected for hematological and biochemical study. Femur bones, brain, and kidneys were dissected and kept in a 
jar containing 10% formalin to perform the histopathological investigation.
Results: The dose of LZD administered for 14 successive days induced a mild-to-moderate hematological abnormalities including decrease in 
hemoglobin content (7.88±0.18 g/L) on day-1 post-treatment. Significant increase in serum urea (59.75±0.85) and serum creatinine was observed 
(1.89±0.04). On day-14 post-treatment, LZD induced mild-to-moderate cellular abnormalities in bone marrow, brain, and kidneys. The concurrent 
oral administration of MEPD and LZD for the same period corrected the hematological, biochemical, and histopathological alterations induced by LZD.
Conclusion: It was concluded that MEPD clearly ameliorated these damaging effects induced by LZD.
Keywords: Phoenix dactylifera, Linezolid, urea, Creatinine, Brain, Bone marrow.
INTRODUCTION
The oxazolidinones represent a new synthetic class of antibacterial 
agents with activity against Gram-positive organisms [1]. Studies 
have shown that the oxazolidinones: Linezolid (LZD) and eperezolid 
are active against vancomycin-resistant staph aureus and penicillin-
resistant Streptococcus pneumoniae [2].
LZD is entering Phase III clinical trials as a therapeutic agent that is 
effective against skin infections, bacteremia, and pneumonia caused by 
Gram-positive pathogenic bacteria, the antimicrobial activities of the 
oxazolidinones were first described by scientists at Dupont de Nemours 
Co., Inc., USA [3].
LZD was discovered in the 1990s and first approved for use in 2000. 
It was the first commercially available 1,3-oxazolidinone antibiotic, 
although others are in development. As a protein synthesis inhibitor, it 
stops the growth of bacteria by disrupting their production of proteins, 
that is, a bacteriostatic agent, not bactericidal. Although many antibiotics 
work this way, the exact mechanism of the action of LZD appears to be 
unique in that it blocks the initiation step of protein production and not 
one of the later steps [4]. Resistance to LZD is extremely rare [5].
In Japan, the use of LZD for MRSA infections was approved in April 
2006. Because the mechanism of the action of LZD differs from that of 
current protein synthesis inhibitors, it is considered to have no cross-
resistance with existing antimicrobial agents [6].
Data on long-term use are limited, but serious neuropathies 
(e.g., peripheral and optic neuropathies), myelosuppression, and 
hyperlactatemia have been observed [7] and are considered to be 
related to the inhibition of mitochondrial protein synthesis [8].
Phoenix dactylifera (PD) is also known as date palm. It is a monocotyledon 
plant within the palm tree family and they can be found mostly in North 
Africa and the Middle East region [9]. They are among a few plants that 
could survive the harsh arid environment and thus are highly regarded 
for the nutritional value that the palm tree fruit provides. In these arid 
regions, where foods are scarce, date palm serves as a good food source 
as they are rich in carbohydrates and they have even become a part of 
Arabian diet. Aside from a common food source, date palm fruits have 
been used traditionally to treat various types of ailments and it has 
been regarded that consumption of the fruit is good for health [10].
Traditional medicines are gaining importance and nowadays are being 
studied to find the scientific basis of their therapeutic actions. The use of 
herbal medicine has become increasingly popular worldwide, especially 
in the Asian and African countries. The various parts of PD are widely 
used in traditional medicine for the treatment of various disorders 
which include memory disturbances, fever, and inflammation [11].
Muslims believe that “he who eats seven dates every morning will not 
be affected by poison or magic on the day he eats them” [12].
The aim of this study is to investigate the possible adverse effects of 
LZD on different biological functions in rats and to find out the possible 




LZD® (Global Napi, Egypt), available as tablets (600 mg/tablet).
Dose: 100 mg/kg b.wt [13].
Tween 80 (Al-Gomhoria Co. Ltd., Egypt).
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Methyl alcohol (Al-Gomhoria Co. Ltd., Egypt).
PD (Siwa oasis, Egypt).
PD fruits
Dose: 1000 mg/Kg (as 25% solution) [14].
Methods
Method of methanolic extraction of PD fruits
About 1 Kg of fresh fruits of PD and pits were prepared and the fresh 
PD fruit (PDF) seeds were removed. The known weight of flesh PDFs 
(FPDFs) was soaked in 1 L methanol (79%) and left for 3 h; then, the 
mixture was blended in a stainless steel blender and the blended 
mixture was sieved twice by narrow mesh stainless steel sieve and the 
sieved part was then added to 2 L of methyl alcohol 79%. The mixture 
was then filtered through sterile absorbed gauze. The residual part of 
dates was soaked in 3 L of methanol 79% and left for 2 h at 20°C, and 
then reblended and refrigerated using the clean gauze. The filtrate was 
added to the previous prepared filtrate and the residual non-filtered 
part was weighed and discarded. The clean part of the supernatant was 
put in the rotary evaporator and adjusted to 42°C, then left for methanol 
to be evaporated. Finally, the resultant crude dates methanolic extract 
was then measured, weighed, and kept in the laboratory refrigerator till 
needed to be administered orally to male albino rats.
Animals and experimental design
Before starting the experiment, we obtained ethical approval from 
Zagazig University, Egypt. Forty-eight adult male albino rats Wistar 
strain weighing 180–200 g were allocated into four equal groups; 
each of 12 animals. The first group was left as control and was given 
0.5 ml Tween 80 orally using the stomach tube daily for 14 consecutive 
days. The second group was given 0.5 ml of LZD (100 mg/kg body 
weight) suspension 4% in Tween 80 PO daily for 14 consecutive days. 
The third group received 0.5 ml of LZD (100 mg/kg body weight) 
suspension 4% in Tween 80 followed by 1 ml of methanolic extract of 
PD (MEPD) (1000 mg/Kg) orally using the stomach tube daily for 14 
consecutive days. The rats in the last group were administered 1 ml of 
PD methanolic extract (1000 mg/Kg) daily for 14 consecutive days by 
oral gavage using the stomach tube.
Sampling
On day-1, 7, and 14 post-treatment, four rats from each group were 
sacrificed and two blood samples were collected into two test tubes 
(EDTA test tube to be used for hematological studies and plain test tube 
without anticoagulant to obtain serum for biochemical studies). After 
that, rats were dissected to remove femur bones, brain, and kidneys to 
be kept in a jar containing neutral formalin 10% at the same periods to 
be used for histopathological study.
Hematological studies
Hematological autoanalyzer (Automatic cell counter: Sysmex KX 21 N, 
Sysmex Co., Japan) was used to determine hematological parameters 
such as red blood cells (RBCs), white blood cells (WBCs), hemoglobin 
(HGB), mean corpuscular volume (MCV), mean corpuscular hemoglobin 
(MCH), mean corpuscular hemoglobin concentration (MCHC), and 
platelets (PLT) [15].
Biochemical study
Serum urea and creatinine were measured using diagnostic kits 
(Spectrum Diagnostics, Obour City, Egypt) [16,17].
Histopathological studies
The formalin preserved the bone marrow, brain, and kidney tissues and 
they were processed in an automated tissue processor. The processing 
consisted of an initial two-step fixation and dehydration. Fixation 
comprising tissue immersion in 10% buffered formalin for 48 h followed 
by removal of fixative in distilled water for 30 min. Dehydration was 
then carried out by running the tissues through a graded series of 
alcohol (70%, 90%, and 100%). The tissue was initially exposed to 70% 
alcohol for 120 min followed by 90% alcohol for 90 min and then two 
cycles of absolute alcohol, each for 1 h. Dehydration was then followed 
by clearing the samples in several changes of xylene. It consisted of 
tissue immersion for an hour in a mixture comprising 50% alcohol 
and 50% xylene followed by pure xylene for 1½ h. Samples were then 
impregnated with molten paraffin wax, then embedded and blocked 
out. Paraffin sections (4–5 µm) were stained with hematoxylin and 
eosin [18]. Stained sections were examined for inflammatory reactions, 
degenerative, necrotic, apoptotic changes, and any other pathological 
lesions in the examined tissues of experimental rats.
Statistical analysis
Data were analyzed using computerized SPSS programs 
version 21 (2001). The results were expressed as mean ± standard 
error of mean. The total variation was analyzed by performing one-way 
analysis of variance. Duncan test was used for determining significance. 
p<0.05 was considered statistically significant [19].
RESULTS AND DISCUSSION
It has been revealed that the oral administration of various treatments 
given daily for 14 days to male albino rats in their recommended doses 
induced non-significant change in thin-layer chromatography except 
with LZD which induced a significant increase (p<0.05) along the entire 
period of the study compared with control group. This elevation may 
be due to posterior leukoencephalopathy induced by LZD [20]. Arshad 
et al. [21] supported our results because they reported that MEPD 
fruits decreased total leukocytic count due to its anti-inflammatory 
effect. LZD is known to cause oxidative stress; this oxidation results in 
increased total leukocytic count, Table 1[22].
Regarding the HGB concentration, it is clear that the administration of 
LZD, MEPD, and their combination for 14 days displayed non-significant 
change during the entire period of the study related to control group 
except with LZD after the 1st day and its combination with MEPD after 
7 days post-treatment which showed a significant decrease and increase 
(p<0.05), respectively, corresponding to control group. A significant 
decrease was observed on day-1 post-treatment with LZD; similar results 
were previously recorded by Birmingham et al. [23] and MacDougall and 
Chambers [24], who reported that one of the adverse effects induced by 
LZD is anemia. Regarding the group received LZD with MEPD that was 
agreeable with Ufelle et al. [25], who reported that MEPD seeds raised the 
HGB concentration in Wistar rats stating the hematopoietic effect of PD.
MCV and MCH value of all groups was not significantly affected along 
the entire course of the study in response to various treatments except 
with LZD after the 1st day post-treatment which displayed a significant 
decrease (p<0.05) compared with control group that coordinated with 
Kofteridis et al. [26], who stated that LZD decreased MCV, PCV, MCH, 
and MCHC. No significant change occurred in MCHC of LZD-treated 
group that needs further investigations.
Our results were not in match with French [27] with reference to the PLT 
count because they mentioned that oral administration of LZD 600 mg 
twice daily PO induced thrombocytopenia after 28 days in humans.
The total RBCs count was not significantly changed along the 
course of the study in response to various treatments except with 
LZD which showed a significant increase on day-7 post-treatment 
(p<0.05) compared with control group. This theory is a compensatory 
mechanism secondary to decreased HGB concentration that leads to 
increase in erythropoietin [28].
Serum urea of LZD-treated group has significantly raised in 
comparison to control group, while the oral administration of LZD 
and its combination with MEPD in their recommended doses and 
time elicited a non-significant change compared with control group, 
whereas the administration of MEPD alone induced non-significant 
changes when compared with control group and a significant decrease 
when compared with LZD or its combination after 7 and 14 days post-
treatment, Table 2.
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On day-1 post-treatment, the dose of LZD given daily for 14 days caused 
a significant increase in serum creatinine. However, various treatments 
induced non-significant changes when compared with control group 
except combination of LZD and MEPD which induced a significant 
decrease corresponding to control group and LZD-treated group. 
On day-14, several treatments induced a significant increase when 
compared with control group except MEPD alone which induced a non-
significant change with control group and a significant decrease when 
compared with LZD alone and its combination with MEPD.
Our results of the kidney function tests agreed with those established by 
Natsumoto et al. [29], who reported that LZD increased serum creatinine 
level in patients received LZD for 7 weeks and this contributes to that 
LZD can cause interstitial nephritis after 3 days as reported by Nayak 
et al. [30]. On administration of LZD and PD combination, our recorded 
results showed a significant decrease in creatinine level, this suggested 
that PD fruits have nephroprotective effect as investigated by Al-Qarawi 
et al. [31], who studied the effect of an extract of the flesh and pits of PD 
on gentamicin-induced nephrotoxicity in rats were effective in reducing 
the increased serum creatinine. Furthermore, our results informed 
that LZD caused a significant increase in the serum urea; these results 
agreed with Lin et al. [32], who stated that LZD mildly elevated urea 
14 days after administration in patients with renal impairment.
Histopathological results
Bone marrow
The bone marrow section of the control group showed numerous 
megakaryocytes with white blood cell and RBCs (Fig. 1a). After 7 days 
post-treatment, the bone marrow section showed hypocellular bone 
Table 1: Effects of oral administration of linezolid (100 mg/Kg body wt), PD methanolic extract (1000 mg/kg body wt), 





Control LZD LZD+MEPD PD
TLC (µl) 9.60±1.20b 17.83±0.52a 12.00±0.56b 11.10±0.43b
HGB (g/l) 12.93±0.36ab 7.88±0.18c 13.55±0.27ab 14.28±0.35a
RBCs count (µl) 6.83±0.26a 8.03±0.27a 7.28±0.42a 7.93±0.10a
MCV (fl) 59.38±1.08a 55.40±0.89b 60.95±0.67a 59.85±0.85a
MCH (pg) 18.03±0.22a 15.98±0.55b 18.83±0.73a 18.08±0.22a
MCHC (g/dl) 31.05±0.27a 26.62±0.53a 30.65±0.94a 30.13±0.26a




Control LZD LZD+MEPD PD
TLC (µl) 9.60±1.20b 17.78±0.72a 12.08±0.05b 9.56±1.30b
HGB (g/l) 12.93±0.36b 15.30±0.41a 15.78±0.38a 12.53±0.24b
RBCs count (µl) 6.83±0.26b 8.52±0.22a 8.78±0.24a 6.44±0.41b
MCV (fl) 59.38±1.08a 54.1±0.46b 57.25±1.06a 59.38±1.08a
MCH (pg) 18.03±0.22a 17.98±0.25a 18.55±0.32a 18.03±0.22a
MCHC (g/dl) 31.05±0.27b 31.25±0.46ab 32.55±0.26a 31.01±0.12b




Control LZD LZD+MEPD PD
TLC (µl) 11.33±0.59b 15.40±0.76a 12.70±0.83ab 11.48±0.89b
HGB (g/l) 13.40±0.64a 13.10±0.17a 14.45±0.32a 13.83±0.50a
RBCs count (µl) 7.44±0.41a 7.22±0.14a 8.13±0.33a 7.69±0.22a
MCV (fl) 56.33±0.71a 57.43±0.72a 56.48±1.39a 57.05±1.11a
MCH (pg) 17.88±0.24a 18.18±0.31a 17.83±0.50a 17.95±0.31a
MCHC (g/dl) 31.13±0.43a 31.65±0.44a 31.58±0.39a 31.50±0.12a
PLT (µl) 705.00±14.34a 578.00±31.37b 719.00±33.08a 623.25±31.05ab
Means within the same column carrying different superscripts are significantly different at p<0.05, PD: Phoenix dactylifera, TLC: Thin-layer chromatography, 
HGB: Hemoglobin, MCV: Mean corpuscular volume, MCHC: Mean corpuscular hemoglobin concentration, PLT: Platelets, RBCs: Red blood cells, MCV: Mean corpuscular 
volume, MCH: Mean corpuscular hemoglobin
Table 2: Effects of oral administration of LZD (100 mg/Kg body wt), PD methanolic extract (1000 mg/kg body wt), and their combination 
given daily for 14 successive days on serum urea and creatinine of rats on day‑1, 7, and 14 post‑treatment. (Mean±SE) (n=4)
Parameter Serum urea (mg/dl) Serum creatinine (mg/dl)
Group Time‑post‑treatment Time‑post‑treatment
1st day 7th day 14th day 1st day 7th day 14th day
Control 27.00±0.71b 27.00±0.71b 45.50±1.04bc 0.75±0.06b 0.75±0.06a 0.85±0.02c
LZD 36.75±1.44a 42.68±1.38a 59.75±0.85a 1.23±0.04a 0.74±0.01a 1.89±0.04a
LZD+PD 37.75±2.95a 44.65±5.01a 48.75±1.11b 1.16±0.09a 0.57±0.02b 1.35±0.02b
PD 31.00±2.12ab 27.77±0.83b 41.00±1.58c 0.97±0.10ab 0.75±0.06a 0.96±0.05c
Means within the same column carrying different superscripts are significantly different at p<0.05. LZD: Linezolid, PD: Phoenix dactylifera
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marrow elements with LZD alone (Fig. 1b). However, the combination 
of both LZD and MEPD, the bone marrow section showed moderate 
increase in the bone marrow elements and scattered fat cells (Fig. 1d), 
whereas normal bone marrow was normal cellularity and numerous 
megakaryocytes surrounded by white blood cell and RBC elements 
were observed as a result of treatment with Phoenix alone after the 
7th day post-treatment (Fig. 1c). Patel and Makhija, [13] supported our 
results, where they found that 100 mg/kg dose of LZD caused bone 
marrow hypocellularity. Onuh et al. [33] also stated that date fruits 
returned bone marrow hypocellularity to its normal state and did not 
differ when compared with control group.
Brain
In Fig. 1e, normal brain tissue from control group showed normal 
neuron cells surrounded by neurological fibers with elongated vascular 
space filled with RBCs. After the 1st day post-treatment with LZD, the 
brain tissue showed aggregates of inflammatory cells surrounding 
dilated vascular space (Fig. 1f), while the group treated with the 
combination of LZD and MEPD showed mild aggregates of inflammatory 
cells (Fig. 2a). On day-1 post-treatment, the group treated with MEPD 
revealed normal neuron cells and neurofilliary material (Fig. 2b).
These histopathological findings on the brain section of LZD-treated 
rats that showed aggregate of inflammatory cells; this is to indicate 
that LZD can highly penetrate CSF [34] and may be contributed to the 
axonal damage to sensory neurons that occur after LZD exposure [35]. 
LZD and Phoenix dactylifera combination showed mild aggregates 
of inflammatory cells. This results agreed with Agbon et al. [14], 
who concluded that PD fruits have neuroprotective effect due to its 
antioxidant properties.
Kidney
The kidney section of the control group showed normal renal glomeruli 
and renal tubules (Fig. 2c). The renal tissue showed moderately dilated 
congested vascular space and mild aggregates of inflammatory cells in 
between glomeruli and renal tubules on day 7 post-treatment with LZD 
alone (Fig. 2d). The combination of both LZD and MEPD led to the absence 
of inflammatory cells with return of the renal tissue to its normal state on 
day 7 post-treatment (Fig. 2f). On day-7, PD treated group showed that 
the renal tissue showed normal structure (Fig. 2e). These results were in 
accordance with Ahmed et al. [36], who concluded that the protection of 
PD seeds extract could be attributed to the total phenol/proanthocyanidin 
content, which can suppress the oxidative stress induced by xenobiotic-
generating free radicals with the subsequent restoration of the 
physiological and histological features of the susceptible organs.
CONCLUSION
The current study reported that the oral administration of the 
therapeutic dose of LZD to male albino rats for 14 consecutive days 
resulted in damaging effects on the bone marrow, brain, and kidneys. It 
was evident that the concurrent oral administration of PD methanolic 
extract (1000 mg/kg b wt.) with LZD (100 mg/kg b wt.) clearly 
counteracted the cellular and biological damaging effects of LZD.
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Fig. 1: (a) Photomicrograph of normal bone marrow of control 
group showing numerous megakaryocytes↑ with white 
blood cell and red blood cell (RBC) elements (H and E, ×400). 
(b) Photomicrograph of bone marrow from rats 7 days post‑
treatment treated with linezolid (LZD) showing hypocellular 
bone marrow elements (H and E, ×400). (c) Photomicrograph 
of normal bone marrow from rats 1 day post‑treatment with 
Phoenix showing normal cellularity of the bone marrow with 
numerous megakaryocytes↑ surrounded by white blood cells 
and RBC elements (H and E, ×400). (d) Photomicrograph of bone 
marrow treated with LZD and Phoenix 7 days post‑treatment 
showing moderate increase in the bone marrow elements 
with scattered fat cells* (H and E, ×200). (e) Photomicrograph 
of normal brain tissue from control group showing normal 
neuron cells↑ surrounded by neurological fibers Δ with 
elongated vascular space filled with RBCs* (H and E ×200). 
(f) Photomicrograph of brain tissue treated with LZD at the 
1st day post-treatment showing aggregates of inflammatory cells↑ 






Fig. 2: (a) Photomicrograph of brain tissue from rats treated with 
LZD and Phoenix at day 1 post‑treatment showed mild aggregates 
of inflammatory cells↑ (H and E, ×200). (b) Photomicrograph 
of brain tissue from rats at day 1 post‑treatment with Phoenix 
showing normal neuron cells↑ and neurofilliary material* 
(H and E, ×200). (c) Photomicrograph of normal rat renal tissue 
of control group showing renal glomeruli↑ and renal tubules* 
(H and E, ×200). (d) Photomicrograph of renal tissue from rats 
7 days post‑treatment with LZD showing moderately dilated 
congested vascular space* and mild aggregates of inflammatory 
cells↑ in between the glomeruli and tubules (H and E, ×200). 
(e) Photomicrograph of renal tissue treated with LZD and Phoenix 
7 days post-treatment showing normal glomeruli↑ and tubules* 
(H and E, ×200). (f) Photomicrograph of renal tissue treated with 
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